Our results highlight a novel mechanism of action of this inhibitor on the SMAD-dependent TGF-β1 pathway, in addition to the already reported anti-cancer role of NCI-41346 on the VEGF pathway [9]. The gene discussed is VEGFA; the disease is cancer.